The relatively low frequency of striatal tauopathy observed in postmortem studies of Parkinson’s disease (PD) brains is possible because tau accumulation is limited to the entorhinal cortex and medial temporal lobe, that is, tauopathy in PD brains may have a defined distribution pattern [5,6]. This evidence concerns the gene MAPT and Parkinson disease.